Pennsylvania – Stock Epinephrine Law
Congratulations! Pennsylvania Governor Tom Corbett signed HB 803 into law on October 31, 2014. This stock epinephrine law law is now known as Act 195 of 2014.
However, our job is not done yet. Each law or regulation must be implemented or put into action by a board or an agency.
Allergy & Asthma Network supports stock epinephrine implementation in schools and provides education and resources to support a seamless rollout. For more information, visit:
- 2016 USAnaphylaxis Summits
- Challenges to Implementing Stock Epinephrine
- National Association of School Nurses Epinephrine Policies, Protocols, and Reporting
See below to find an ACE team in Pennsylvania.
Matthew Fogg, MD, MA of Allergy & Asthma Specialists
Philadelphia and Collegeville, PA
Blue Bell, PA
Richard Schwarz, MD of Allergy, Asthma & Arthritis Associates
Susan Bulette, RN, Heather Fredericks, and Janel Pauser
Rachel Hamdan, RN of Children’s Hospital of Philadelphia
Stacy Chiles, RN of McKean Elementary School
Allison Freeman, MD of West Penn Hospital-Allegheny Health Network
Sandra Gawchik, DO of Asthma and Allergy Associates
Denise Kalman, DO of Asthma and Allergy Associates
Andrew Murphy, MD of Allergy Asthma & Sinus Center
West Chester, PA
ACE Team Activities:
Dr. Allison Freeman and her team provided an ACE presentation, “Gettting Ready for School: Anaphylaxis Preparedness Panel Discussion” to approximately 50 local school nurses, parents, students, and press on August 5, 2015 at the Wexford Health + Wellness Pavilion in Wexford, PA. They reviewed anaphylaxis symptoms and treatment, how to avoid triggers, and how to develop an anaphylaxis plan. The ACE team raised awareness about anaphylaxis, educated audience about symptoms and treatment of anaphylaxis, and demonstrated all commercially available EAIs. Evaluation forms were recorded.
On July 17-19, 2015, Ms. Chiles provided a 3-day anaphylaxis training course to 16 school nurses in Western Pennsylvania.
On October 20, 2016, Dr. Gawchik provided clinical expertise about latex allergy during a Network webinar panel presentation titled, “Overcoming Barriers in the Real World– A Look at Clinical Issues, School Concerns and Living with Latex Allergy”
On October 6, 2015, Dr. Gawchik presented a webinar titled “Be Aware, Latex Allergy & Anaphylaxis Are Still Here!” for 72 registrants.
Dr. Gawchik supervised 12 pediatric residents during the course 2014. Each resident spent four weeks under Dr. Gawchik’s supervision. During this time, Dr. Gawchik reviewed with them the signs and symptoms and treatment for anaphylaxis. In addition, she also provided them with relevant medical articles for them to read.
In 2014, Dr. Kalman completed many advocacy activities, including obtaining stock epinephrine for schools and advocating for passage of evidence-based anaphylaxis-related legislation. Dr. Kalman impacted legislation in both Pennsylvania and Delaware, changed anaphylaxis policies and procedures, and increased anaphylaxis awareness. DE’s stock epinephrine bill passed in record time–13 days from introduction to landing on the Governor’s desk.
In November 2014, Dr. Sigrid DaVeiga was interviewed for an article about a patient of hers with a rare citrus allergy.
Questions about state legislation, ACE activities or getting involved?
About Anaphylaxis Community Experts (ACEs):
Anaphylaxis Community Experts is a national, award-winning education, advocacy and outreach partnership program developed and hosted by The Network and the American College of Allergy, Asthma & Immunology, sponsored by Mylan Specialty L.P.